• Tidak ada hasil yang ditemukan

Perbandingan Kadar Serum Matrix Metalloproteinase (Mmp)-7 Pada Gastritis H.Pylori Dengan Non H.Pylori

N/A
N/A
Protected

Academic year: 2017

Membagikan "Perbandingan Kadar Serum Matrix Metalloproteinase (Mmp)-7 Pada Gastritis H.Pylori Dengan Non H.Pylori"

Copied!
7
0
0

Teks penuh

(1)

DAFTAR PUSTAKA

1. El-Zimaity HMT. Recent advances in the histopathology of gastritis.

Current Diagnostic Pathology. 2007;13:340-8.

2. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al.

Gastritis: the histology report. Digestive and Liver Disease. 2011;

43S:S373–84.

3. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. J Clin

Invest. 2007b;17:60-9.

4. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and

molecular diagnosis of Helicobacter pylori in benign lesions and gastric

adenocarcinoma. Braz J Microbiol. 2005;36(1):261-6.

5. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar

S. Unveiling the Intricacies of Helicobacter pylori-induced Gastric

Inflammation: T Helper cells and Matrix Metalloproteinases at a

Crossroad. In: Mozsik G, editor. Current Topics in Gastritis. Croatia:

InTech Publishers; 2013. Chapter 7.

6. K Awwad , A. Alenezy, M. Taha, Hasan M. Helicobacter pylori

associated chronic gastritis: Endoscopic and pathological findings,

comparative study. March 2014. 6(2), pp.23-28.

7. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A,

et al. Decreasing prevalence of helicobacter antibodies in Finland, with

reference to the decreasing incidence of gastric cancer. Epidemiol Infect.

2001;126:37-42.

8. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.

Genetic differences in interleukin-1 betapolymorphisms among four Asian

populations: an analysis of the Asian paradox between H. pylori infection

and gastric cancer incidence. J Exp Clin Cancer Res. 2003; 22: 47-55.

9. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.

(2)

in patients with Helicobacter pylori infection. Tokai J Exp Clin Med.

2005;30(2):83-8.

10. Andersen LP, Holck S, Janulaityte-Gu¨nther D, Kupcinskas L, Kiudelis G,

Jonaitis L, et al. 2005. Gastric inflammatory markers and interleukins in

patients with functional dyspepsia, with and without Helicobacter pylori

infection.FEMS Immun and Med Microbiol; 44:233–238.

11. Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagstrom J,

et al. MMP-7 overexpression is an independent prognostic marker in

gastric cancer. Tumor Biol. 2010; 31: 149-155.

12. S. Georgina, Butler, M. Christopher. Matrix metalloproteinase processing

of signaling molecules to regulate inflamation. Periodontology 2000. Vol

63, 2013; 123-148

13. Caruso R, Fina D, Peluso I, et all. IL-21 Is Highly Produced in

Helicobacter pylori-Infected Gastric Mucosa and Promotes Gelatinases Synthesis. J Immunol 2007; 178: 5957-5965.

14. Krakowiak MS, Noto JM, PlazueloMB et al. Matrix metalloproteinase-7

restrains Helicobacter pylori-induced gastric inflamation and premalignant

lesions in the stomach by altering macrophage polarization. Oncogene

2014, 1-7.

15. Hellmig S, ott S, Rosenstiel P et al. Genetic Variants in Matrix

metalloproteinase genes are associated with development of gastric ulcer

in H. Pylori infection. AmJ Gastroenterol 2006.

16. Rautelin HI, Oksanen AM, Veijola LI et al. Enhanced systemic matrix

metalloproteinase response in Helicobacter pylori gastritis. AnnMed,

2009; 41: 208-215.

17. Toljamo K. Gastric erosions – clinical significance and pathology.A

long-term follow-up study. University of Oulu, Finland:Acta Univ Oul;

2012.hlm 1-80.

18. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal

Publishing : 2009 ; 509-512.

(3)

20. Adibi P. Gastritis. [Diunduh 19 Mei 2014]. Tersedia dari:

http://med.mui.ac.ir

21. Szoke D. Genetic factors related to the histological and macroscopic

lesions of the stomach. [disertasi]. Budapest: Semmelweis University;

2009. Hlm 7-61.

22. Wehbi M, Acute gastritis Medscape. 2014.

23. Simadibrata M. Dyspepsia and Gastroesophageal Reflux Disease (GERD):

Is There Any Correlation? Acta Med Indones. 2009; 41(4): 222-7.

24. Silva MIG, de Sousa FCF.Gastric ulcer etiology. In: Chai J, editor. Peptic

Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.

25. Syam AF, Sadikin M, Wanandi SI, Rani AA. Molecular mechanism on

healing process of peptic ulcer.Acta Med Indones. 2009;41(2):95-8.

26. Brzozowski T. Experimental production of peptic ulcer, gastric damage

and cancer models and their use in pathophysiological studies and

pharmacological treatment–polish achievement.J Phyl Pharmacol.

2003;54:99-126.

27. Wallace JL. Prostaglandins, NSAIDs, and Gastric Mucosal Protection:

Why Doesn’t the Stomach Digest Itself. American Physiological Society.

Physiol Rev 88: 1547-1565, 2008.

28. Cheung R, Cheng TT, Dong Y, Lin HY, Lai K, Lau CS, et al.

2010.Incidence of gastroduodenal ulcers during treatment with celecoxib

or diclofenac: pooled results from three 12-week trials in Chinese patients

with osteoarthritis or rheumatoid arthritis. Int J Rheum Dis;13(2): 151–7.

29. Chung HW, Lim JB. Role of the tumor microenvironment in the

pathogenesis of gastric carcinoma. World J Gastroenterol 2014; 20(7):

1667-1680.

30. Zakaria Z. The role of interleukin-10 in Helicobacter pylori infection.

Master [Tesis]. Nottingham,UK: University of Nottingham; 2010.hlm. 55.

31. Lew E. Peptic ulcer disease. Greenberger NJ, editor. Current Diagnosis

and Treatment Gastroenterology, Hepatology, and Endoscopy. New York:

(4)

32. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng

(Kudingcha) prevents HCl/ethanol induced gastric injury in Sprague

Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.

33. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami

H, et al. 2009. Lansoprazole, a Proton Pump Inhibitor, Suppresses

Production of Tumor Necrosis Factoralpha and Interleukin-1beta Induced

by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in

Human Monocytic Cells via Inhibition of Activation of Nuclear

Factor-kappaB and Extracellular Signal-Regulated Kinase. J Clin Biochem Nutr;

45(1):86–92.

34. Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of

Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the

proton pump inhibitor pantoprazole against indomethacin-induced gastric

damage in rats. BMC Gastroenterol. 2012;12:143.

35. Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew

N, Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal

Anti-Inflammatory Drugs-Induced Gastropathy in Rats. Thai J

Gastroenterol. 2013; 14(2):87-92.

36. Eamlamnam K, Patumraj S, Visedopas N, et al. Effects of Aloe vera and

sucralfate on gastric microcirculatory changes, cytokine levels and gastric

ulcer healing in rats. World J Gastroenterol 2006;12:2034-9.

37. Naito Y, Yoshikawa T, Yagi N, Matsuyama K, Yoshida N, Seto K, et al.

Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and

TNF- expression in rats with aspirin-induced gastric mucosal injury. Dig

Dis Sci. 2001;46:845–51.

38. Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis

extract against NSAID induced gastric ulcer: role of proinflammatory

cytokines and oxidative damage. Chem Biol Interact. 2006;161:262–70.

39. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S,

Drozdowicz D, et al. Activation of genes for superoxide dismutase,

(5)

molecule-1 during healing of ischemia-reperfusion-induced gastric injury.

Scand J Gastroenterol. 2000;35(5):452-63.

40. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter

pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.

41. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation.

British Med Bull. 1998;54:139-50.

42. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H.

Interleukin 1beta polymorphisms increase risk of hypochlorhydria and

atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.

Gastroenterology. 2002;123(1):92-105.

43. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10

signaling blocks inhibitor of kappaB kinase activity and nuclear factor

kappaB DNA binding. J Biol Chem. 1999;274:31868-74.

44. Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR.The role of

NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal

epithelial cells.Cytokine.2006; 36:1-8.

45. Sampieri CL, Cordoba KL, Troche JMR, 2013. Matrix metalloproteinases

and their tissue inhibitors in gastric cancer as molecular markers. Review

Article.Journal of Cancer Research and Therapeutics. 2013.Vol 9-Issue 3.

46. McCaig C, Duval C, Hemers E et al. The role of matrix

metalloproteinase-7 in redefining the gastric microenvironment in respons to helicobacter

pylori. Gastroenterol 2006.

47. Ashraf GMd, Sheikh IA. Advances in Protein Chemistry: Role of Matrix

Metalloproteinases in Cancer; September 2013.

48. Langers AM, Verspaget HW, Hommes DW, Sier CFM. Single-nucleotide

polymorphisms of matrix metallopreteinases and their inhibitors in

gastrointestinal cancer. World J Gastro oncol, 2011; 3(6): 79-98.

49. Wroblewski LE, Peek RM. Orchestration of Dysregulated Epithelial

Turnover by a Manipulative Pathogen. Cell host & Microbe 2. October

(6)

50. Dahlan MS. Statistik untuk kedokteran dan kesehatan.Salemba

Medika.2012;3:26.

51. Sander GB, Mazzoleni LE, Francesconi CFM, Wortmann AC, Andre E,

Theil A, Piccoli VDC, Da Silva AC, et al. Development and Validation of

a Cross-Cultural Questionnaire to Evaluate Nonuclear Dyspepsia: The

Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ). Dig Dis Sci,

Vol. 49, Nos 11/12 (November/December 2004).

52. Peek RM, Fiske C, Wilson KT. Role of Innate Immunity in Helicobacter

pylori-Induced Gastric Malignancy. Physiol Rev 2010: 90: 831-858.

53. Pandeya N, Whitmen DC, Australian Cancer Study. Prevalence and

determinants of H.Pylori sero-positivity in the australian community. J

Gastroenterol Hepatology.2011 Aug;26(8);1283-9.

54. Zhu Y, et al. Risk factors and prevalence of H.Pylori infection in

persistent high incidence area of gastric carcinoma in Yangzhong

city.2014. .http://dx.doi.org/10.1155/2014/481365.

55. Seyda T, Derya C, Fusun A, Meliha K. The relationship of helicobacter

pylori positivity with age, sex and ABO/Rhesus blood groups in patients with gastrointestinal complaints in turkey. Helicobacter, June 2007; 12(3):

244-250

56. Naja F,et al. Helicobacter pylori in Ontario : prevalence and rsik factors.

Jurnal canadian of gastroenterol, 2007;21(8):501-506.

57. Bebb JR, Thomas RJ, Collins HM, et al. Helicobacter pylori upregulates

matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag

dependent manner. Gut 2003; 52: 1408-1413.

58. Crawford HC, Krishna US, Israel DA, et al. Helicobacter pylori

Strain-Selective Induction of Matrix Metalloproteinase-7 In Vitro and Within

Gastric Mucosa. Gastroenterol 2003; 125: 1125-1136.

59. Rautelin IH, Oksanen AM, Veijola LI, et al. Enhanced systemic matrix

metalloproteinase response in Helicobacter pylori gastritis. Ann Med,

(7)

60. Yin Y, Grabowska AM, Clarke PA, et al. Helicobacter pylori potentiates

epithelial : mesenchymal transition in gastric cancer: links to soluble

HB-EGF, gastrin and matrix metalloproteinase-7. Gut 2010; 59: 1037-1045.

61. Chung WC, Jung SH, Lee KM, et al. The detection of Helicobacter pylori

cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and

intramucosal cancer. Gastric Cancer 2010;13:162-169.

62. Bode G, Rothenbacher D, Brenner H, Adler G. Helicobacter pylori and

abdominal symptoms: a population-based study among preschool children

in southern Germany. Pediatrics 1998;101:634-7.

63. Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not

correlate with gastritis grade and Helicobacter pylori infection in non ulcer

dyspepsia. Trop Gastroenterol 2001;22:194-6.

64. Kasifoglu N, Akgun Y, Saricam T, Kiremitci A, Tercan. IL-8 Serum level

in patients with Helicobacter pylori infection and relation between

serological markers. African Journal of Microbiology 2009 ;11:822-25.

65. Dandin AS, Jayashree P, Athanikar V.S. H. pylori associated gastritis.

Referensi

Dokumen terkait

Tujuan dari penelitian ini adalah untuk mengetahui waktu baku /waktu standar dari pembuatan pintu depan bbus skania sehingga mendapatkan output standar yang dihasilkan ,keseluruhan

[r]

Tujuan dari penelitian ini adalah untuk mengetahui komponen-komponen dari produk, mengetahui proses produksi, mengetahui waktu siklus yang dibutuhkan untuk penyelesaian

LAMPIRAN PERATURAN MENTERI PENDIDIKAN DAN KEBUDAYAAN NOMOR 10 TAHUN 2012.. TENTANG WAJIB LAPOR

Karena itu penulis menggunakan Home Page untuk memberikan informasi apa saja yang ada di TMII, supaya pemuda-pemuda sekarang tidak akan menganggap TMII adalah tempat rekreasi

Ketentuan mengenai penyimpanan arsip aktif dan inaktif yang telah ditetapkan dengan Keputusan Menteri Pendidikan Nasional Nomor 145/U/2004 tentang Jadwal Retensi Arsip

Dalam Peraturan ini, yang dimaksud dengan pendidikan inklusif adalah sistem penyelenggaraan pendidikan yang memberikan kesempatan kepada semua peserta didik yang memiliki kelainan

Pada hari ini, Rabu tanggal Empat belas bulan Januari tahun Dua ribu lima belas, Unit Layanan Pengadaan (ULP) SPN Singaraja Tahun 2015 telah melaksanakan